Welcome to Abbott's fourth quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by Abbott. With the exception of any participants' questions asked during the question-and-answer session,

Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street estimates, along with weak fourth-quarter sales in segments other than medical devices, sending its shares down 1% in premarket trading.

Abbott Laboratories is forecasting profit for 2025 in line with Wall Street’s estimates as the health care company said strong demand for its medical devices will continue to drive growth.